1. Punjabi S, Cook LJ, Kersey P, Marks R, Cerio R.
    Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study.
    Int J Dermatol. 2008;47(1):78-82.

  2. Liang CH, Shiu LY, Chang LC, Sheu HM, Tsai EM, Kuo KW.
    Solamargine Enhances HER2 Expression and Increases the Susceptibility of Human Lung Cancer H661 and H69 Cells to Trastuzumab and Epirubicin.
    Chem Res Toxicol. 2008; 18;21(2):393-9.

  3. Shiu LY, Liang CH, Huang YS, Sheu HM, Kuo KW.
    Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu.
    Cell Biol Toxicol. 2008;24(1):1-10.

  4. Lawson CJ, Wilson A W-W, Steroid modified chacotrioses and solatrioses US Patent Application No 2007/0066814, 22.03.2007

  5. Shiu LY, Chang LC, Liang CH, Huang YS, Sheu HM, Kuo KW.
    Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.
    Food Chem Toxicol. 2007;45(11):2155-64.

  6. Yang SA, Paek SH, Kozukue N, Lee KR, Kim JA.
    Alpha-chaconine, a potato glycoalkaloid, induces apoptosis of HT-29 human colon cancer cells through caspase-3 activation and inhibition of ERK 1/2 phosphorylation.
    Food Chem Toxicol. 2006;44(6):839-46.

  7. Dembitsky VM.  Astonishing diversity of natural surfactants: 6. Biologically active marine and terrestrial alkaloid glycosides. Lipids. 2005;40(11):1081-105. Review.

  8. Lawson CJ Solvent extraction process (alkaloid glycosides) US Patent Application No 2004/0249138, 12.09.2004

  9. Liu LF, Liang CH, Shiu LY, Lin WL, Lin CC, Kuo KW.
    Action of solamargine on human lung cancer cells--enhancement of the susceptibility of cancer cells to TNFs. FEBS Lett. 2004;577(1-2):67-74.

  10. Liang CH, Liu LF, Shiu LY, Huang YS, Chang LC, Kuo KW.
    Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells.
    Biochem Biophys Res Commun. 2004;322(3):751-8.

  11. Lee KR, Kozukue N, Han JS, Park JH, Chang EY, Baek EJ, Chang JS, Friedman M.
    Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver
    (HepG2) cancer cells. J Agric Food Chem. 2004; 19;52(10):2832-9.

  12. Roddick JG, Weissenberg M, Leonard AL.
    Membrane disruption and enzyme inhibition by naturally-occurring and modified chacotriose-containing Solanum steroidal glycoalkaloids.
    Phytochemistry. 2001;56(6):603-10.

  13. Morillo M, Lequart V, Grand E, Goethals G, Usubillaga A, Villa P, Martin P.
    Synthesis of peracetylated chacotriose. Carbohydr Res. 2001;334(4):281-7.

  14. Kuo KW, Hsu SH, Li YP, Lin WL, Liu LF, Chang LC, Lin CC, Lin CN, Sheu HM.
    Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells. Biochem Pharmacol. 2000;60(12):1865-73.

  15. Hu, K., Kobayashi, H., Dong, A., Jing, Y., Iwasaki, S. and Yao, X.  Antineoplastic agents III: steroidal glycosides from Solanum nigrum. Planta Med.1999, 65, 35-38.

  16. Ren, W. and Tang, D.G. Extract of Solanwn muricatum (Pepino/CSG) inhibits tumor growth by inducing apoptosis.  Anticancer Res.1999; 19, 403-408.

  17. Chang LC, Tsai TR, Wang JJ, Lin CN, Kuo KW.
    The rhamnose moiety of solamargine plays a crucial role in triggering cell death by apoptosis.
    Biochem Biophys Res Commun. 1998;242(1):21-5.

  18. Chataing B, Concepción JL, Lobatón R, Usubillaga A.
    Inhibition of Trypanosoma cruzi growth in vitro by Solanum alkaloids: a comparison with ketoconazole.  Planta Med. 1998; 64(1):31-6.

  19. Weissenberg M, Levy A, Svoboda JA, Ishaaya I.  The effect of some Solanum steroidal alkaloids and glycoalkaloids on larvae of the red flour beetle, Tribolium castaneum, and the tobacco hornworm, Manduca sexta.  Phytochemistry. 1998;47(2):203-9.

  20. Roddick JG.  Steroidal glycoalkaloids: nature and consequences of bioactivity.
    Adv Exp Med Biol. 1996;404:277-95. Review.

  21. Hsu SH, Tsai TR, Lin CN, Yen MH, Kuo KW.  Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis.  Biochem Biophys Res Commun. 1996;229(1):1-5.

  22. Fewell AM, Roddick JG, Weissenberg M.  Interactions between the glycoalkaloids solasonine and solamargine in relation to inhibition of fungal growth.  Phytochemistry. 1994;37(4):1007-11.

  23. Dixit, V.P., Varma, M., Mathur, NT., Mathur, R and Sharma, S. Hypocholesterolaemic and antiatherosclerotic effects of solasodine (C27H43O2N) in cholesterol fed rabbits. Phytother Res.1992; 6, 270-273.

  24. Cham BE, Daunter B, Evans RA.  Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides.
    Cancer Lett. 1991;59(3):183-92.

  25. Cham BE, Daunter B.  Solasodine glycosides. Selective cytotoxicity for cancer cells and inhibition of cytotoxicity by rhamnose in mice with sarcoma 180.  Cancer Lett. 1990; 55(3):221-5.

  26. Cham BE, Meares HM.  Glycoalkaloids from Solanum sodomaeum are effective in the treatment of skin cancers in man. Cancer Lett. 1987;36(2):111-8.